VRCA · Verrica Pharmaceuticals Inc.
$4.97
+0.11 (+2.26%)
At close · Aug 14
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has concluded that substantial doubt exists regarding its ability to continue as a going concern within one year after the date these consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$87.44M
Shares
17.18M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-06 | 21,220 | 52,182 | 73,402 | 41.8% |
| 2026-06-29 | 18,543 | 44,765 | 63,308 | 39.7% |
| 2026-06-22 | 41,253 | 139,374 | 180,627 | 53.1% |
| 2026-06-15 | 13,909 | 23,345 | 37,254 | 32.8% |
| 2026-06-08 | 29,229 | 68,623 | 97,852 | 46.4% |
| 2026-06-01 | 26,363 | 58,897 | 85,260 | 47.1% |
| 2026-05-25 | 23,637 | 42,972 | 66,609 | 50.3% |
| 2026-05-18 | 38,224 | 83,268 | 121,492 | 50.9% |
| 2026-05-11 | 90,985 | 155,980 | 246,965 | 50.2% |
| 2026-05-04 | 148,980 | 162,749 | 311,729 | 39.6% |
| 2026-04-27 | 73,556 | 94,128 | 167,684 | 55.2% |
| 2026-04-20 | 88,891 | 50,935 | 139,826 | 38.4% |
| 2026-04-13 | 149,682 | 105,498 | 255,180 | 46.7% |
| 2026-04-06 | 128,334 | 69,317 | 197,651 | 46.1% |
| 2026-03-30 | 44,187 | 63,265 | 107,452 | 35.4% |
| 2026-03-23 | 97,223 | 147,157 | 244,380 | 48.0% |
| 2026-03-16 | 123,135 | 275,864 | 398,999 | 44.9% |
| 2026-03-09 | 194,409 | 186,274 | 380,683 | 38.5% |
| 2026-03-02 | 106,462 | 122,699 | 229,161 | 41.4% |
| 2026-02-23 | 40,151 | 101,730 | 141,881 | 40.3% |
| 2026-02-16 | 262,277 | 136,052 | 398,329 | 60.0% |
| 2026-02-09 | 165,893 | 201,729 | 367,622 | 47.6% |
| 2026-02-02 | 111,023 | 222,648 | 333,671 | 38.4% |
| 2026-01-26 | 38,070 | 60,206 | 98,276 | 26.4% |
| 2026-01-19 | 159,512 | 202,197 | 361,709 | 59.7% |
| 2026-01-12 | 323,037 | 323,212 | 646,249 | 58.5% |
| 2026-01-05 | 250,328 | 160,441 | 410,769 | 49.7% |
| 2025-12-29 | 136,493 | 245,403 | 381,896 | 45.1% |
| 2025-12-22 | 82,770 | 102,652 | 185,422 | 35.0% |
| 2025-12-15 | 131,558 | 332,287 | 463,845 | 34.3% |
| 2025-12-08 | 124,349 | 253,475 | 377,824 | 43.0% |
| 2025-12-01 | 167,369 | 684,725 | 852,094 | 44.7% |
| 2025-11-24 | 272,147 | 2,365,732 | 2,637,879 | 57.0% |
| 2025-11-17 | 65,929 | 289,733 | 355,662 | 54.3% |
| 2025-11-10 | 26,536 | 144,222 | 170,758 | 46.3% |
| 2025-11-03 | 24,518 | 132,702 | 157,220 | 52.7% |
| 2025-10-27 | 40,086 | 149,192 | 189,278 | 44.7% |
| 2025-10-20 | 86,971 | 1,241,245 | 1,328,216 | 34.7% |
| 2025-10-13 | 43,520 | 149,301 | 192,821 | 47.4% |
| 2025-10-06 | 46,968 | 1,013,754 | 1,060,722 | 37.3% |
| 2025-09-29 | 22,558 | 124,048 | 146,606 | 59.0% |
| 2025-09-22 | 43,023 | 257,995 | 301,018 | 48.3% |
| 2025-09-15 | 72,732 | 3,472,301 | 3,545,033 | 41.6% |
| 2025-09-08 | 8,079 | 57,867 | 65,946 | 55.2% |
| 2025-09-01 | 16,340 | 56,329 | 72,669 | 54.7% |
| 2025-08-25 | 10,048 | 135,625 | 145,673 | 54.4% |
| 2025-08-18 | 10,120 | 60,483 | 70,603 | 45.0% |
Showing 1–47 of 47 weeks
Key facts
CIK
1660334
CUSIP
92511W207
13F (30d)
42 filings
42 filers
Visit website
Investor relations